Gregory Morris has joined O’Melveny as a partner in its intellectual property and technology practice group in New York, the law firm announced Monday.
Morris focuses on pharmaceutical, biotechnology, and medical technology patent litigation, according to the firm.
He joins the firm from Honigman in Chicago, where he established the firm’s life science IP litigation practice, O’Melveny said.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.